RAN and laryngotracheoesophageal cleft: Analysis of subjects with T3 stage showed a decrease of CT heterozygote occurrence of RAN rs14035 polymorphism (OR: 0.2401, 0.95 CI: 0.1133–0.509, and p < 0.0001 [pcorr = 0.001], Table 3(b)) in LC patients compared to healthy subjects.